Cargando…
Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers
Relaxin-2 exerts many favourable cardiovascular effects in pathological circumstances such as atrial fibrillation (AF) and heart failure, but the mechanisms underlying its actions are not completely understood. Since inflammation and fibrosis are pivotal processes in the pathogenesis of AF, our aim...
Autores principales: | Aragón-Herrera, Alana, Couselo-Seijas, Marinela, Feijóo-Bandín, Sandra, Anido-Varela, Laura, Moraña-Fernández, Sandra, Tarazón, Estefanía, Roselló-Lletí, Esther, Portolés, Manuel, Martínez-Sande, José Luis, García-Seara, Javier, Álvarez, Ezequiel, González-Juanatey, José Ramón, Rodríguez-Mañero, Moisés, Eiras, Sonia, Lago, Francisca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789945/ https://www.ncbi.nlm.nih.gov/pubmed/36566255 http://dx.doi.org/10.1038/s41598-022-26836-1 |
Ejemplares similares
-
Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases
por: Aragón-Herrera, Alana, et al.
Publicado: (2022) -
Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future Perspectives
por: Feijóo-Bandín, Sandra, et al.
Publicado: (2017) -
Adipokines and Inflammation: Focus on Cardiovascular Diseases
por: Feijóo-Bandín, Sandra, et al.
Publicado: (2020) -
Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models
por: Feijóo-Bandín, Sandra, et al.
Publicado: (2022) -
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
por: Aragón-Herrera, Alana, et al.
Publicado: (2022)